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Lekarz Ewelina Kowalczyk jest absolwentką Wydziału Lekarskiego Uniwersytetu Medycznego w Łodzi. 
Obecnie odbywa szkolenie specjalizacyjne w Klinice Kardiologii Wojewódzkiego Specjalistycznego 
Szpitala im. dr. Władysława Biegańskiego w Łodzi pod kierownictwem prof. dr. hab. n. med. Jarosława 
D. Kasprzaka. Jej rozprawa doktorska dotyczy charakterystyki funkcji śródbłonka naczyniowego oraz 
funkcji mięśnia sercowego z zastosowaniem zaawansowanych metod echokardiograficznych w grupie 
młodych dorosłych chorych na cukrzycę typu 1. Zainteresowania medyczne skupia na diagnostyce nie-
inwazyjnej chorób układu sercowo-naczyniowego. Wolny czas spędza z dwójką dzieci.
Abstract
Introduction. Data describing prognostic utility of SPECT (single-photon emission computed tomography) among pa-
tients with history of myocardial infarction (MI) is scarce. We aimed to compare prognostic value of SPECT scans in 
patients with vs. without history of myocardial infarction (MI) prior to perfusion imaging.
Material and methods. 151 consecutive patients with history of myocardial infarction, who underwent exercise 99mTc-MIBI 
SPECT examination were enrolled in the study (group 1). Next, based on clinical and demographic baseline characteristics, 
SPECT result and duration of follow-up period, a matching control subgroup (group 2) of 151 patients without history of MI 
was formed. During a mean follow-up of 60 ± 15 months in group 1 and a mean follow-up of 60 ± 13.5 months in group 2, 
we analyzed prevalence of cardiovascular events rates (cardiac deaths, myocardial infarctions and cardiac revascularizations).
Results. We observed the following rates of cardiac deaths, myocardial infarctions and cardiac revascularizations: 4%, 
15% and 26%, respectively in group 1 and 1%, 13% and 17%, respectively in group 2. In patients without history of MI 
(group 2) presence of mixed perfusion defects on SPECT was associated with significantly higher rate of myocardial 
infarctions (p = 0.05), hospitalizatons (p = 0.0001) and revascularizations (p = 0.0002). Fixed perfusion defects were 
associated with significantly higher occurrence of deaths (p = 0.012) and hospitalizations (p = 0.02), but not myocardial 
infarctions (p = 0.52) or cardiac revascularizations (p = 0.10). In contrast, among patients with history of MI (group 1) 
there was no statistically significant relationship between any type of perfusion defects and cardiovascular events.
Conclusions. Long term follow-up demonstrates that prognostic value of 99mTc-MIBI SPECT is different in patients with 
and without history of MI.
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Introduction
Over the past two decades advances in the clinical man-
agement of myocardial infarction (MI) have improved over-
all patients’ survival [1, 2]. As the population of post-MI 
patients increases, more information about cardiovascular 
risk stratification in this patient population is needed in 
our clinical practice.
Single-photon emission computed tomography (SPECT) 
myocardial perfusion imaging is a widely used non-invasive 
modality with well-established prognostic value [3, 4]. Ho-
wever, the data documenting its prognostic value are based 
mainly on the populations with suspected or known coro-
nary artery disease. Whether similar prognostic value can 
be expected in patients with history of MI remains unclear.
The aim of our study is to compare a prognostic utility 
of SPECT between patients with and without past history 
of myocardial infarction prior to perfusion imaging.
Material and methods
Study population
151 consecutive patients with documented history of MI 
who underwent 99mTc-MIBI SPECT examination were includ-
ed in the study. Patients who had MI within 6 months prior 
to the SPECT examination were not enrolled. All patients 
suffered from angina and were referred for the examina-
tion by the attending physicians. Subsequently, the control 
group of 151 patients without history of MI were matched 
one to one according to baseline demographic and clinical 
characteristics (age, sex, left ventricle ejection fraction, 
history of hypertension and diabetes), SPECT scan result 
(normal, induced, mixed or fixed defects) and duration of 
follow-up time. The baseline characteristics of both groups 
are shown in Table 1.
SPECT protocol
All patients underwent stress-rest myocardial perfusion 
SPECT using two-day protocol. On the first day, patients un-
derwent treadmill exercise test and received intravenously 
99mTc-methoxyisobutylisonitrile (weight adjusted dose of 11 
MBq/kg) at the peak of exercise. Imaging data were record-
ed using a circular 180° acquisition (from 45° left anterior 
oblique to 45° right posterior oblique) for 64 projections at 
20 s/projection. On the second day the same dose of the 
radiotracer was administered at rest and resting images 
were obtained as described above. SPECT perfusion studies 
were reconstructed using a filtered back projection method, 
without attenuation correction. Series of tomograms were 
assessed visually by experienced observers and with the 
Cedar Sinai algorithm based on polar maps. Based on the 
SPECT scan results the myocardial perfusion were classified 
as: normal (without perfusion abnormalities), with induci-
ble defect(s) (reversible, stress-induced ischemia), mixed 
(irreversible ischemia + reversible), or fixed (irreversible) 
defect(s).
Clinical follow-up
The clinical follow-up regarding cardiovascular events was 
obtained by reviewing patients’ records and telephone 
interviews. The following end-points were included in the 
analysis: cardiac deaths, myocardial infarctions, revascu-
larizations (including percutaneous transluminal coronary 
angioplasty and coronary artery bypass graft) and cardiac 
hospitalizations. The revascularizations performed within 
3 months from SPECT examination were not included in 
the analysis.
Statistical analysis
The data was tested for normal distribution using the 
D’Agostino-Pearson test. Continuous variables are pre-
Table 1. Baseline characteristics of study population. Data is presented as arithmetic mean ± standard deviation or percentage (number 
of patients)
Group 1 (151 pts) Group 2 (151 pts)
Male 57% (86 pts) 57% (86 pts)
Mean age (years) 59 ± 9.4 59 ± 8.6
Mean follow-up duration (months) 60 ± 15 60 ± 13.5
Left ventricle ejection fraction [%] 55±11 55±7
Hypertension 50% (75 pts) 50% (76 pts)
Diabetes 9% (14 pts) 10% (15 pts)









pts — patients; SPECT — single-photon emission computed tomography
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sented as an arithmetic mean and ± standard deviation or 
median with minimum and maximum value. The association 
between type of perfusion defect and mentioned end-
points during follow-up period was assessed by perform-
ing a Kaplan-Meier survival analysis. Also, hazard ratios 
for cardiovascular endpoinsts were calculated for each 
perfusion defect. Results were considered as statistically 
significant if p ≤ 0.05. All calculations were performed with 
MedCalc version 10.4.8.0 statistical software package 
(MedCalc, Belgium).
Results
The median time from myocardial infarction to SPECT 
examination in group 1 was 4 years (range from 0.5 to 16 
years). After a mean follow-up period of 60 ± 15 months 
(group 1) and 60 ± 13.5 (group 2) the following rates of 
cardiac deaths, myocardial infarctions and cardiac revascu-
larizations were observed: 4%, 15% and 26%, respectively 
in group 1 and 1%, 13% and 17%, respectively in group 2.
In patients without history of MI (group 2) presence of 
mixed perfusion defects on SPECT was associated with 
significantly higher risk of myocardial infarctions (p = 0.05), 
hospitalizatons (p = 0.0001) and revascularizations (p = 
0.0002) (Table 2). Fixed perfusion defects were associated 
with significantly higher occurrence of deaths (p = 0.012) 
and hospitalizations (p = 0.02), but not myocardial in-
farctions (p = 0.52) or cardiac revascularizations (p = 0.10).
In contrast, among patients with history of MI (group 1) 
there was no statistically significant relationship between 
any type of perfusion defects and cardiovascular events 
(Table 3).
Discussion
Our study proved that prognostic utility of SPECT scans are 
different for patients with and without prior history of MI 
(regardless the similar baseline characteristic).
Data from nationwide registries concerning patients’ 
outcome after MI showed, that even 10% of patients 
had recurrent MI during the first 3 years [2, 5] and 17% 
required subsequent revascularization during 5 years [6]. 
Thus, the prediction of adverse events in individuals after 
MI is necessary.
To date, majority of studies concerning prognostic utility 
of SPECT imaging have been conducted on patients with 
known or suspected coronary artery disease (CAD). Based 
on this evidence, reversible defects are associated with MI 
and fixed defects (irreversible defects) are associated with 
cardiac deaths [7]. These findings are in agreement with our 
observations among patients without history of MI (group 
2). In this group mixed perfusion defects were associated 
with cardiac revascularizations and myocardial infarctions, 
while fixed defects were associated with cardiac deaths. 
These conclusions cannot be strictly applied to patients 
with previous MI. Our study shows that among patients with 
Table 2. Occurrence of cardiovascular end-points (cardiac death, cardiac hospitalization, myocardial infarction, revascularization) in pa-
tients from group 2 (without history of myocardial infarction prior the single-photon emission computed tomography examination) depen-
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prior history of MI, perfusion defects cannot discriminate 
future cardiovascular events. Regrettable, there is a lack 
of similar studies in post MI population with which we can 
compare our results.
A normal SPECT result is associated with an excellent 
very long term prognosis [8, 9], even among patients with 
past history of MI [8–10] or CAD confirmed by coronary 
angiography [11]. The annual hard event rate (cardiac 
death or nonfatal MI) for a normal SPECT result is about 
0.6% while for an abnormal scan is 12-fold higher [12]. The 
current study also confirms this observation.
Study limitations
This is a single-center study with a relatively small group 
of patients. Therefore, these results need to be validated 
in a larger, multi-center study. Another limitation is a lack 
of analysis of infarct and perfusion defects size. The as-
sessment of extent of total perfusion abnormality, espe-
cially the extent of reversible (inducible) defects [13–15] 
or infarct size [16, 17] may enhance the predictive utility 
of SPECT.
Conclusions
The myocardial perfusion SPECT imaging remains a very 
useful tool for risk stratification among patients with known 
or suspected CAD and no MI history. However, our study 
shows, that predictive utility of SPECT among patients with 
pervious history of MI is limited.
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Streszczenie
Wstęp. W dostępnej literaturze brakuje badań służących ocenie przydatności prognostycznej scyntygrafii perfuzyjnej 
mięśnia sercowego SPECT (tomografia emisyjna pojedynczego fotonu) w grupie chorych z wywiadem przebytego zawału 
serca. Celem opisanego badania jest porównanie wartości prognostycznej SPECT w grupie pacjentów z wywiadem za-
wału serca przed badaniem SPECT oraz bez takiego wywiadu.
Table 3. Occurrence of cardiovascular end-points (cardiac death, cardiac hospitalization, myocardial infarction, revascularization) in pa-
tients from group 1 (with history of myocardial infarction prior the single-photon emission computed tomography examination) depending 
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Materiał i metody. Do badania włączono 151 kolejnych pacjentów z wywiadem zawału serca, u których wykonano ba-
danie SPECT z użyciem 99mTc-MIBI. Następnie, na podstawie charakterystyki klinicznej i demograficznej oraz długości 
okresu obserwacji dobrano, grupę kontrolną 151 pacjentów poddanych badaniu SPECT, bez wywiadu wcześniejszego 
zawału serca.
Wyniki. Po średnim okresie obserwacji 60 ± 15 miesięcy (grupa 1) i 60 ± 13,5 miesiąca (grupa 2) częstość wystąpienia 
punktów końcowych, takich jak zgon z przyczyn sercowo-naczyniowych, zawał serca, rewaskularyzacja, wyniosła odpo-
wiednio 4%, 15% i 26% w grupie 1 oraz 1%, 13%, 17% w grupie 2. Wśród pacjentów bez wywiadu zawału serca (grupa 
2) obecność mieszanych zaburzeń perfuzji w badaniu SPECT wiązała się z istotnie większą częstością zawałów serca (p 
=0,05), hospitalizacji (p = 0,0001) oraz rewaskularyzacji (p = 0,0002). Utrwalone zaburzenia perfuzji wiązały się z istot-
nie większą liczbą zgonów z przyczyn sercowo-naczyniowych, liczbą hospitalizacji (p=0,02), ale nie zawałów serca (p = 
0,52) ani rewaskularyzacji (p = 0,10). Natomiast wśród pacjentów bez wywiadu zawału serca (grupa 1) nie zaobserwowa-
no istotnej statystycznie zależności między typem zaburzeń perfuzji a występowaniem powyższych punktów końcowych.
Wnioski. W długoterminowej obserwacji wykazano różnicę w zakresie wartości rokowniczej badania SPECT między 
pacjentami po przebytym zawale serca oraz bez wywiadu zawału.
Słowa kluczowe: SPECT, zawał serca, rokowanie, scyntygrafia perfuzyjna
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